Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2

DMM Disease Models and Mechanisms

Volumn 4, Issue 2, 2011, Pages 203-211

  Lieu, Shirley ^a   Hansen, Erik ^a   Dedini, Russell ^a   Behonick, Danielle ^a   Werb, Zena ^a   Miclau, Theodore ^a   Marcucio, Ralph ^a   Colnot, Céline ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B; ILOMASTAT; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CALLUS; CARTILAGE; CARTILAGE FRACTURE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; ENZYME DEFICIENCY; FRACTURE HEALING; FRACTURE NONUNION; HYBRIDIZATION; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLAST ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; BONE REMODELING; DIPEPTIDES; FRACTURE HEALING; HUMANS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; OSTEOGENESIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

MUS;

EID: 79952336084     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.006304     Document Type: Article

References (28)

1. Behonick, D. J., Xing, Z., Lieu, S., Buckley, J. M., Lotz, J. C., Marcucio, R. S., Werb, Z., Miclau, T. and Colnot, C. (2007). Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration. PLoS ONE 2, e1150.
2. Biswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H. and Nabeshima, K. (1995). The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 55, 434-439.
3. Colnot, C., Thompson, Z., Miclau, T., Werb, Z. and Helms, J. A. (2003). Altered fracture repair in the absence of MMP9. Development 130, 4123-4133.
4. Corry, D. B., Kiss, A., Song, L. Z., Song, L., Xu, J., Lee, S. H., Werb, Z. and Kheradmand, F. (2004). Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. FASEB J. 18, 995-997. (Pubitemid 39561503)
5. Cowell, S., Knauper, V., Stewart, M. L., D'Ortho, M. P., Stanton, H., Hembry, R. M., Lopez-Otin, C., Reynolds, J. J. and Murphy, G. (1998). Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem. J. 331, 453-458. (Pubitemid 28182159)
6. Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174. (Pubitemid 37328786)
7. Geoffroy, V., Marty-Morieux, C., Le Goupil, N., Clement-Lacroix, P., Terraz, C., Frain, M., Roux, S., Rossert, J. and de Vernejoul, M. C. (2004). In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J. Bone Miner. Res. 19, 811-822.
8. Greenlee, K. J., Corry, D. B., Engler, D. A., Matsunami, R. K., Tessier, P., Cook, R. G., Werb, Z. and Kheradmand, F. (2006). Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J. Immunol. 177, 7312-7321. (Pubitemid 44715101)
9. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I. et al. (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92. (Pubitemid 29468632)
10. Holmbeck, K., Bianco, P., Pidoux, I., Inoue, S., Billinghurst, R. C., Wu, W., Chrysovergis, K., Yamada, S., Birkedal-Hansen, H. and Poole, A. R. (2005). The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J. Cell Sci. 118, 147-156.
11. Howard, E. W., Bullen, E. C. and Banda, M. J. (1991). Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J. Biol. Chem. 266, 13064-13069. (Pubitemid 21907308)
12. Inoue, K., Mikuni-Takagaki, Y., Oikawa, K., Itoh, T., Inada, M., Noguchi, T., Park, J. S., Onodera, T., Krane, S. M., Noda, M. et al. (2006). A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J. Biol. Chem. 281, 33814-33824. (Pubitemid 46036758)
13. Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T. and Itohara, S. (1997). Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem. 272, 22389-22392. (Pubitemid 27386043)
14. Kato, T., Kure, T., Chang, J. H., Gabison, E. E., Itoh, T., Itohara, S. and Azar, D. T. (2001). Diminished corneal angiogenesis in gelatinase A-deficient mice. FEBS Lett. 508, 187-190.
15. Lee, S., Jilani, S. M., Nikolova, G. V., Carpizo, D. and Iruela-Arispe, M. L. (2005). Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J. Cell Biol. 169, 681-691.
16. Lu, C., Miclau, T., Hu, D., Hansen, E., Tsui, K., Puttlitz, C. and Marcucio, R. S. (2005). Cellular basis for age-related changes in fracture repair. J. Orthop. Res. 23, 1300-1307. (Pubitemid 41554661)
17. Martignetti, J. A., Al Aqeel, A., Al Sewairi, W., Boumah, C. E., Kambouris, M., Al Mayouf, S., Sheth, K. V., Al Eid, W., Dowling, O., Harris, J. et al. (2001). Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat. Genet. 28, 261-265. (Pubitemid 32626029)
18. McCawley, L. J. and Matrisian, L. M. (2001). Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol. 13, 534-540.
19. Mosig, R. A., Dowling, O., DiFeo, A., Ramirez, M. C., Parker, I. C., Abe, E., Diouri, J., Aqeel, A. A., Wylie, J. D., Oblander, S. A. et al. (2007). Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum. Mol. Genet. 16, 1113-1123. (Pubitemid 47062731)
20. Mott, J. D. and Werb, Z. (2004). Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol. 16, 558-564. (Pubitemid 39201241)
21. Ortega, N., Behonick, D. J., Colnot, C., Cooper, D. N. and Werb, Z. (2005). Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol. Biol. Cell 16, 3028-3039. (Pubitemid 40741245)
22. Ortega, N., Wang, K., Ferrara, N., Werb, Z. and Vu, T. H. (2010). Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis. Model. Mech. 3, 224-235.
23. Page-McCaw, A., Ewald, A. J. and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233.
24. Parks, W. C., Wilson, C. L. and Lopez-Boado, Y. S. (2004). Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4, 617-629. (Pubitemid 39025047)
25. Stickens, D., Behonick, D. J., Ortega, N., Heyer, B., Hartenstein, B., Yu, Y., Fosang, A. J., Schorpp-Kistner, M., Angel, P. and Werb, Z. (2004). Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131, 5883-5895. (Pubitemid 40123905)
26. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422. (Pubitemid 28232085)
27. Wiseman, B. S., Sternlicht, M. D., Lund, L. R., Alexander, C. M., Mott, J., Bissell, M. J., Soloway, P., Itohara, S. and Werb, Z. (2003). Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162, 1123-1133. (Pubitemid 37174194)
28. Zhou, Z., Suneel, S. A., Raija, S., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y. and Tryggvason, K. (2000). Impaired endochrondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1. Proc. Natl. Acad. Sci. USA 97, 4052-4057. (Pubitemid 30226085)